Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P594: Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Blesl*1, F. Rainer1, P. Wurm1, M. Durdevic1, W. Petritsch1, H. Wenzl1, F. Baumann-Durchschein1, A. Posch1, A. Streit1, G. Gorkiewicz1, H-P. Gröchenig2, P. Kump1, C. Högenauer1

1Medical University of Graz, Graz, Austria, 2Barmherzige Brüder St. Veit/Glan, St. Veit, Austria

P595: Early medical therapy and risk of subsequent perianal fistula development among paediatric patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Adler*1,2, C. C. Lin3, S. Gadepalli2,4, K. Dombkowski2

1University of Michigan, Pediatric Gastroenterology, Ann Arbor, USA, 2University of Michigan, Child Health Evaluation and Research (CHEAR) Center, Ann Arbor, USA, 3University of Michigan, Health Services Research Program, Department of Neurology, Ann Arbor, USA, 4University of Michigan, Pediatric Surgery, Ann Arbor, USA

P596: An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

M. A. Aardoom*1, P. Kemos2, F. Ruemmele3, N. Croft2, L. de Ridder1, PIBD SETQuality consortium and PIBDnet1

1Erasmus Medical Center - Sophia Children's Hospital, Paediatric gastroenterology, Rotterdam, The Netherlands, 2Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, Paediatric gastroenterology, London, UK, 3Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paediatric gastroenterology, Paris, France

P597: Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Berends*1,2, K. Bloem3, R. Talwar1, A. De Vries3, T. Schaap3, A. Strik2, M. Löwenberg2, G. D'Haens2, R. Mathôt1

1Amsterdam UMC - location AMC, Hospital Pharmacy, Amsterdam, The Netherlands, 2Amsterdam UMC - location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3Sanquin Diagnostic Services, Biologics Lab, Bioanalysis, Amsterdam, The Netherlands

P598: Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Ogata*1, T. Hagiwara2, Y. Ito2, T. Kawaberi2, M. Kobayashi2, T. Hibi3

1Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Tokyo, Japan, 2AbbVie GK, Tokyo, Japan, 3Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan

P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Wall*1, B. Wilson1, J. Sanderson2, M. Lomer1,3

1King's College London, Department of Nutritional Sciences, London, UK, 2Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, UK, 3Guy's and St Thomas' NHS Foundation Trust, London, UK

P600: Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Eberl*1, T. Hallinen2, C-G. af Björkesten3, M. Heikkinen4, E. Hirsi5, M. Kellokumpu6, I. Koskinen7, V. Moilanen8, C. Nielsen9, H. Nuutinen10, U-M. Suhonen11, K. Utriainen12, I. Vihriälä13, E. Soini2, C. Wennerström14, R. Nissinen15, A. Borsi16, M. Koivunen15, J. Tillonen17, T. Sipponen1

1Helsinki University Hospital, Clinic of Gastroenterology, Helsinki, Finland, 2Esior Oy, Kuopio, Finland, 3Helsinki University Hospital/Jorvi Hospital, Department of Gastroenterology, Espoo, Finland, 4Kuopio University Hospital, Department of Internal Medicine, Kuopio, Finland, 5South Karelia Central Hospital, Department of Internal Medicine, Lappeenranta, Finland, 6Lapland Central Hospital, Department of Internal Medicine, Rovaniemi, Finland, 7Central Hospital of Central Finland, Department of Internal Medicine, Jyväskylä, Finland, 8Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland, 9Vaasa Central Hospital, Department of Internal Medicine, Vaasa, Finland, 10Turku University Hospital, Division of Gastroenterology, Department of Medicine, Turku, Finland, 11Kainuu Central Hospital, Department of Internal Medicine, Kajaani, Finland, 12Turku University Hospital/Salo hospital, Division of Gastroenterology, Department of Medicine, Salo, Finland, 13Central Ostrobothnia Central Hospital, Department of Internal Medicine, Kokkola, Finland, 14Janssen-Cilag AB, Medical Affairs, Solna, Sweden, 15Janssen-Cilag Oy, Medical Affairs, Espoo, Finland, 16Janssen-Cilag Limited, EPC - HEMAR, Buckinghamshire, UK, 17Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland

P601: Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Mateos1, E. Sáez1,2, I. Moret1,3, D. Hervás4, L. Tortosa1,3, E. Cerrillo2,3, M. Iborra2,3, M. García2, P. Nos1,2,3, B. Beltrán1,2,3

1IIS Hospital La Fe, Gastroenterology, Valencia, Spain, 2Hospital Universitari i Politècnic La Fe, Gastroenterology, Valencia, Spain, 3CIBEREHD, Madrid, Spain, 4IIS Hospital La Fe, Biostatistics, Valencia, Spain

P602: CD-TREAT a novel dietary therapy of active Crohn’s disease using the exclusive enteral nutrition paradigm

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Svolos*1, R. Hansen2, U. Z. Ijaz3, L. Gervais2, H. Duncan2, R. Tayler2, A. Barclay2, D. Flynn2, V. Garrick2, L. Curtis2, E. Buchanan2, T. Cardigan2, D. R. Gaya4, S. Milling5, R. K. Russell2, K. Gerasimidis1

1Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK, 2Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK, 3School of Engineering, University of Glasgow, Glasgow, UK, 4Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK, 5Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

P603: Paediatric onset inflammatory bowel disease is not associated with more disability compared with adult onset disease

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Picardo*1, R. Panaccione1, G. Kaplan1,2, C. Seow1,2, J. deBruyn3, Y. Leung1,4

1Univeristy of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada, 2University of Calgary, Community Health Sciences, Calgary, Canada, 3Univeristy of Calgary, Pediatric Gastroenterology, Calgary, Canada, 4University of British Columbia, Inflammatory Bowel Disease Unit, Vancouver, Canada

P604: Biologics with or without a combination with 5-ASA in ulcerative colitis: frequency of usage and effect on the course of disease in the Swiss IBD-Cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Roth*1, P. Schreiner1, J-B. Rossel2, B. Misselwitz3, M. Scharl1, G. Rogler1, L. Biedermann1

1University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 3University Hospital Bern, Department of Visceral Surgery and Medicine, Bern, Switzerland

P605: CRP reduction rate following initiation of anti-tumour necrosis factor-α induction therapy predicts secondary loss of response in patients with Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. H. Song*1, S. N. Hong1, T. J. Kim1, E. R. Kim1, D. K. Chang1, Y-H. Kim1

1Samsung Medical Center, Department of Medicine, Seoul, South Korea

P606: Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Smolovic*1, M. Lukic1, O. Sekulic1, D. Muhovic1, V. Milosevic2, B. Vukcevic3

1Clinical Center of Montenegro, Podgorica, Montenegro, 2Ars Medica, Podgorica, Montenegro, 3Faculty of Medicine, University of Montenegro, Podgorica, Montenegro

P607: Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Narula1, B. Lauzon*1, J. Marshall1

1McMaster University, Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute, Hamilton, ON, Canada

P608: Crohn’s disease patients with high baseline symptoms achieve clinical remission more rapidly with Budesonide than with Mesalazine

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Kunz*1, R. Hofmann1

1Tillotts Pharma AG, Rheinfelden, Switzerland

P609: Handsewn anastomosis after ileo-colic resection for Crohn’s disease: a lost art?

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Gouvea Monteiro de Camargo1, S. Brandstetter1, A. Aiello2, L. Stocchi1, T. Hull1, I. Lavery1, J. M. Church1, S. R. Steele1, M. Valente1, S. Holubar*1

1Cleveland Clinic Foundation, Colorectal Surgery, Cleveland, USA, 2Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland, USA

P610: Penetration, short- and long-term efficacy of anti-TNF-α therapy for ulcerative colitis between 2010–2016 in Hungary

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Molnár*1, F. Nagy1, Z. Szepes1, K. Farkas1, R. Bor1, A. Bálint1, Á. Milassin1, A. Fábián1, M. Rutka1, K. Szántó1

1University of Szeged, First Department of Medicine, Szeged, Hungary

P611: A real-world assessment of golimumab effect on quality of life, healthcare resource utilisation and work productivity in patients with ulcerative colitis in Greece: interim results from the GO-LIFE study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Mantzaris*1, A. Gatopoulou2, D. Christodoulou3, K. Katsanos3, I. Mouzas4, M. Tzouvala5, G. Paspatis6, K. Thomopoulos7, S. Michopoulos8, G. Koujlakis9, I. Pachiadakis10, K. Triantafyllou11, P. Karatzas12, D. Moschovis13, G. Theocharis7, M. Tampaki14

1Evangelismos-Ophthalmiatreion Athinon-Polykliniki Hospital, Gastroenterology, Athens, Greece, 2University Hospital of Alexandroupoli, Democritus University of Thrace, 2nd Department of Internal Medicine, Alexandroupoli, Greece, 3University Hospital of Ioannina, Gastroenterology, Ioannina, Greece, 4University of Crete, Medical School, Gastroenterology, Heraklion, Greece, 5General Hospital of Nikea and Piraeus, Agios Panteleimon – Agia Varvara., Gastroenterology, Nicea, Greece, 6Venizeleio Pananeio General Hospital of Heraklion, Gastroenterology, Heraklion, Greece, 7University Hospital of Patras, Medical School, Gastroenterology, Patras, Greece, 8Alexandra General Hospital of Athens, Gastroenterology, Athens, Greece, 9Democritus University of Thrace, Digestive System Endoscopy Unit, Alexandroupoli, Greece, 10424 Military General Hospital, Gastroenterology and Hepatology, Thessaloniki, Greece, 11Second Department of Internal Medicine - Propaedeutic, Research Institute and Diabetes Center, Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hepatogastroenterology Unit, Athens, Greece, 12Evangelismos Hospital, Gastroenterology, Athens, Greece, 13General Hospital of Nikea and Piraeus, Agios Panteleimon – Agia Varvara, Gastroenterology, Nicea, Greece, 14Merck Sharp and Dohme Pharmaceutical, Industrial and Commercial S.A, Athens, Greece

P612: Long-term outcomes of treatment intervention according to the severity of small bowel capsule endoscopy findings in patients with Crohn’s disease: A Japanese single-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Nasuno*1, H. Tanaka1, K. Sugiyama1, M. Miyakawa1, S. Motoya1

1Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan

P613: Tacrolimus as rescue therapy for steroid-dependent/steroid refractory ulcerative colitis: experience from tertiary referral centre

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Sud*1, A. S. Puri1

1GB Pant Institute of Postgraduate Medical Education and Research, Gastroenterology, New Delhi, India